ScoreComparison
Why is AnaptysBio, Inc. ?
1
The company has declared Positive results for the last 7 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 4.48 MM
- NET SALES(HY) At USD 133.81 MM has Grown at 88.77%
- NET PROFIT(HY) Higher at USD -3.27 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 268.87%, its profits have risen by 90.9%
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating performance in long term as well as near term
- Along with generating 268.87% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to AnaptysBio, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is AnaptysBio, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
AnaptysBio, Inc.
288.43%
1.98
72.35%
S&P 500
25.22%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
25.62%
EBIT Growth (5y)
31.99%
EBIT to Interest (avg)
-10.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.26
Tax Ratio
0.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
44.35
EV to EBIT
33.76
EV to EBITDA
32.14
EV to Capital Employed
386.87
EV to Sales
6.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1145.84%
ROE (Latest)
-35.56%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend23What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 4.48 MM
NET SALES(HY)
At USD 133.81 MM has Grown at 88.77%
NET PROFIT(HY)
Higher at USD -3.27 MM
ROCE(HY)
Highest at -114.55%
RAW MATERIAL COST(Y)
Fallen by 0.22% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 10.65 times
-15What is not working for the Company
NET SALES(Q)
At USD 25.56 MM has Fallen at -56.43%
CASH AND EQV(HY)
Lowest at USD 598.09 MM
OPERATING PROFIT(Q)
Lowest at USD -34.03 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -133.15 %
PRE-TAX PROFIT(Q)
Lowest at USD -52.84 MM
NET PROFIT(Q)
Lowest at USD -52.88 MM
EPS(Q)
Lowest at USD -1.84
Here's what is working for AnaptysBio, Inc.
Operating Cash Flow
Highest at USD 4.48 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Highest at 10.65 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by 0.22% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for AnaptysBio, Inc.
Net Sales
At USD 25.56 MM has Fallen at -56.43%
over average net sales of the previous four periods of USD 58.65 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -52.84 MM has Fallen at -1,517.51%
over average net sales of the previous four periods of USD -3.27 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -52.88 MM has Fallen at -1,498.67%
over average net sales of the previous four periods of USD -3.31 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Profit
Lowest at USD -34.03 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at -133.15 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at USD -52.84 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -52.88 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -1.84
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Cash and Eqv
Lowest at USD 598.09 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
